Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Rakovina Therapeutics Inc
V.RKV
Alternate Symbol(s):
RKVTF
Rakovina Therapeutics Inc. is a Canada-based biopharmaceutical research company. The Company is focused on the development of new cancer treatments based on novel deoxyribonucleic acid (DNA)-damage response technologies. Its drug development pipeline includes kt-2000AI and kt-3000 series. It is engaged in employing the proprietary Deep Docking AI Platform to rapidly screen billions of potential...
drug candidates against PARP (kt-2000AI) and other novel DDR targets to generate drug candidates that can be advanced to human trials or developed in collaboration with pharmaceutical partners. Its kt-3000 series represents a novel class of bi-functional small-molecule drug candidates that has been designed to combine inhibition of both poly (ADP)-ribose polymerase (PARP) and histone deacetylase (HDAC) in a single molecule. This novel approach has the potential to overcome treatment resistance and provide clinical benefit to cancer patients.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:RKV)
New Post
View:
Posts & Comments
Threaded Posts
(35)
•••
bmreed
X
View Profile
View Bullboard History
Post by
bmreed
on Oct 25, 2024 1:08pm
News Update w RKV Executive Chairman Jeffrey Bacha
(35)
•••
bmreed
X
View Profile
View Bullboard History
Post by
bmreed
on Oct 01, 2024 12:56pm
Webinar Recap w $RKV Executive Chairman Jeffrey Bacha
(35)
•••
bmreed
X
View Profile
View Bullboard History
Post by
bmreed
on Sep 18, 2024 8:47pm
Webinar $RKV Executive Chair Jeffrey Bacha Sep 24 @ 1PM ET
Live Webinar - Rakovina Therapeutics (RKV) w/ Executive Chairman Jeffrey Bacha Tuesday, September 24th at 1PM ET / 10AM PT Q&A with Radius Research Register Here - https://us02web
...more
(8)
•••
sharonw
X
View Profile
View Bullboard History
Post by
sharonw
on Aug 30, 2023 2:08pm
RKV at an offline event
How surprsing is that? I think it is solid info that RKV gonna attend an offline event https://ow.ly/b6wJ50PG2Qh. Its about time we check it out and see what this company really about!
(28)
•••
anjz661
X
View Profile
View Bullboard History
Comment by
anjz661
on Jun 15, 2022 8:44pm
RE:2021 Financial Results/Provides Corporate Update TSXV:RKV
https://www.rakovinatherapeutics.com/
(3217)
•••
Betteryear2
X
View Profile
View Bullboard History
Post by
Betteryear2
on Apr 27, 2022 6:55pm
2021 Financial Results/Provides Corporate Update TSXV:RKV
VANCOUVER, British Columbia, April 27, 2022 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV, the “Company”) a biopharmaceutical company committed to advancing new cancer therapies based on
...more
(3217)
•••
Betteryear2
X
View Profile
View Bullboard History
Post by
Betteryear2
on Apr 12, 2022 9:07am
Rakovina Therapeutics Presents Preclinical Data Supporting
VANCOUVER, British Columbia, April 12, 2022 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (“the Company”), a biopharmaceutical company committed to advancing new cancer therapies based
...more
(3217)
•••
Betteryear2
X
View Profile
View Bullboard History
Post by
Betteryear2
on Nov 17, 2021 8:06am
InvestmentPitch Media Video
Vancouver, British Columbia--(Newsfile Corp. - November 17, 2021) - Rakovina Therapeutics Inc. (TSXV: RKV), a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA
...more
(3217)
•••
Betteryear2
X
View Profile
View Bullboard History
Post by
Betteryear2
on Nov 16, 2021 6:26pm
The Power Play by The Market Herald Releases New Interviews
Rakovina (RKV) is partnering with St. Baldrick's Foundation to develop treatments for childhood bone cancer. It was selected to join a three-year C$1,297,000 research program funded by St
...more
(433)
•••
AwareInvestor
X
View Profile
View Bullboard History
Post by
AwareInvestor
on Apr 08, 2021 9:27am
Rakovina Therapeutics Granted Patents For Drug Candidates
Rakovina Therapeutics has received patents as of this morning. Granted by both the European and Canadian patent offices, the patents are for “Tricyclic Inhibitors of Poly(ADP-Ribose) Polymerase”.
...more
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
One Property, One Focus on Advancing this Gold Project in Ontario
Options Trading for Retiring: Key Strategies in Balancing Retirement Income